1. Ahmed, T., Bosl, G.J., and Hajdu, S.I. (1985). Teratoma with malignant transformation in germ cell tumours in man. Cancer 56: 860–863.
2. Andrews, P.W., Banting, G., Damjanov, I., Arnaud, D., and Avner, P. (1984b). Three monoclonal antibodies defining distinct differentiation antigens associated with different high molecular weight polypeptides on the surface of human embryonal carcinoma cells. Hybridoma 3: 347–361.
3. Andrews, P.W. and Damjanov, I. (1985) Immunochemistry of human teratocarcinoma stem cells. In: Sell, S., Reisfeld, R.A. (eds.) Monoclonal antibodies in cancer. Humana Press. Clifton, New Jersey, pp. 339–364.
4. Andrews, P.W., Damjanov, I., Simon, D., Banting, G.S., Carlin, C., Dracopoli, N.C., Fogh, J. (1984a). Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Laboratory Investigation 50: 147–162.
5. Andrews, P.W., Oosterhuis, J.W. and Damjanov, I. (1987). Cell lines from human germ cell tumours. In: E.J. Robertson (ed.) Teratocarcinomas and embryonic stem cells: a practical approach. IRL Press, Oxford, pp. 207–248.